Heart and liver intertwined, symbolizing the connection between BNP levels and fatty liver disease.

Low BNP Levels Linked to Fatty Liver Disease in Type 2 Diabetes: What You Need to Know

Nico Varela monogram
Nico Varela in Health & Wellness October 2026 • 4 min read.

"New research suggests a connection between heart health and liver health in type 2 diabetes. Could monitoring BNP levels be a new way to assess liver disease risk?"


Non-alcoholic fatty liver disease (NAFLD) is a growing concern, especially for those with type 2 diabetes. It’s characterized by an excessive buildup of fat in the liver, and it can lead to serious health issues, including cardiovascular problems. Managing NAFLD is crucial, and new research is shedding light on unexpected connections within the body.

Recent studies have highlighted the role of natriuretic peptides (NPs), particularly B-type natriuretic peptide (BNP), in regulating metabolism. These peptides, traditionally known for their heart-related functions, appear to influence how the body processes fats. Low levels of NPs have been observed in individuals with obesity and type 2 diabetes, potentially affecting fat distribution and increasing the risk of NAFLD.

A groundbreaking study has uncovered a significant link between low levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), a precursor to BNP, and the presence of NAFLD in patients with type 2 diabetes. This discovery opens new avenues for understanding the interplay between heart health, metabolic processes, and liver disease.

AI Search Multiple angles on this topic

Fatty Liver and Health Claims

Fatty liver disease is characterized by excess fat accumulating in the liver, according to Healthline. A Consumer Health Digest review of Fatty 15 reports that the supplement may support metabolism, mood, overall health, weight loss, and liver function. These snippets do not establish a specific prevalence of fatty liver disease or prove that Fatty 15 improves low BNP levels in people with type 2 diabetes.

Assessing Fatty Liver

Without subsection-specific sources, standard methods for evaluating fatty liver should be described cautiously. In general, clinicians may consider a person’s history, symptoms, laboratory findings, and imaging, but the appropriate approach depends on the individual case. The available material does not support specific claims about diagnostic accuracy, treatment limitations, or BNP testing.

An Evolving Understanding

The history of fatty liver research has developed alongside broader understanding of liver fat, metabolic disease, and cardiovascular health. However, no subsection-specific sources were provided to verify particular discoveries, dates, or milestones. Any detailed historical account would therefore require additional evidence.

The BNP-NAFLD Connection: Unpacking the Research

Heart and liver intertwined, symbolizing the connection between BNP levels and fatty liver disease.

In a cross-sectional study, researchers investigated the relationship between NT-proBNP levels and liver fat content in 120 patients with type 2 diabetes. Liver fat was precisely measured using 1H-magnetic resonance spectroscopy, a sophisticated imaging technique. The study aimed to determine if there’s a correlation between BNP levels and the presence of NAFLD.

The results revealed that nearly half (48%) of the participants had NAFLD, defined as a liver fat content exceeding 5.6%. These individuals also exhibited significantly lower NT-proBNP levels compared to those without NAFLD. This intriguing finding suggests a potential link between BNP deficiency and the development of fatty liver disease.

Here are some key findings:
  • Individuals with NAFLD had lower NT-proBNP levels.
  • Lower NT-proBNP was associated with a 2.9-fold increased risk of NAFLD, even after adjusting for factors like age, gender, and other health conditions.
  • NT-proBNP levels were independently and inversely associated with liver fat content, meaning that as NT-proBNP levels decreased, liver fat increased.
AI Search Multiple angles on this topic

Current Evidence

No subsection-specific sources were provided for a review of the latest research. It is therefore not possible to characterize the strength, size, or findings of recent studies linking BNP levels with fatty liver disease in type 2 diabetes. Claims about new mechanisms or clinical applications should remain provisional until supported by research evidence.

Limits of the Evidence

The available subsection material does not document failed studies, contradictory findings, or counterarguments about low BNP levels. A cautious interpretation is appropriate because an observed association would not by itself establish causation. More detailed conclusions would require sources addressing confounding factors, study design, and replication.

Comparisons Require Evidence

No sources were supplied for comparing BNP levels, fatty liver subtypes, diagnostic methods, or treatment strategies. Such comparisons should not be inferred from general descriptions of fatty liver disease. Differences among patient groups or tests would need to be evaluated using directly relevant studies.

The researchers further explored the roles of insulin resistance and fat metabolism. They found that the relationship between BNP and liver fat might be influenced by adiponectin, a hormone that regulates glucose levels and fatty acid breakdown. This suggests that the connection between BNP and NAFLD may involve complex interactions within fat tissue.

What This Means for You

This research offers valuable insights into the intricate relationship between heart and liver health, particularly for individuals with type 2 diabetes. Monitoring BNP levels could potentially become a useful tool in assessing the risk of NAFLD. While further studies are needed, this discovery highlights the importance of a holistic approach to managing diabetes, considering the interconnectedness of various bodily systems. If you have type 2 diabetes, discussing your BNP levels with your healthcare provider may be a proactive step in understanding your overall health and potential risk for NAFLD.

AI Search Multiple angles on this topic

Interpreting the Association

The available material supports only a cautious synthesis. Fatty liver refers to excess fat in the liver, while the specific relationship between low BNP and fatty liver disease in type 2 diabetes cannot be evaluated from the sources provided here. Expert interpretation would require direct clinical evidence rather than general health or supplement claims.

Questions for Future Research

Future research could clarify whether low BNP is a reproducible marker associated with fatty liver disease in people with type 2 diabetes. It could also examine whether the finding has diagnostic or prognostic value. No subsection-specific sources were provided to support predictions about particular technologies, therapies, or timelines.

A Complex Health Context

Fatty liver disease sits within a broader health context that may involve metabolic and cardiovascular concerns. Still, the provided material does not document healthcare-system barriers, disparities, costs, or population-level effects related to low BNP and type 2 diabetes. Those issues should be discussed only with appropriately targeted evidence.

Individualized Care

For individuals, a finding involving BNP or liver fat may raise questions about risk, testing, and treatment. The available sources do not show how patients experience this association or how it changes day-to-day care. People should therefore avoid treating general supplement or disease descriptions as personalized medical guidance.

What the NT-proBNP change means in a healthy population

  • approximately 25% lowerIn the generally healthy population described, the combination of fatty liver and insulin resistance was associated with NT-proBNP levels about 25% lower. The comparison is with levels in that population without the combined indicators; the excerpt does not give an absolute starting level.[1]

How liver fat fits broader metabolic and heart evidence

The diabetes-focused finding used magnetic resonance spectroscopy to quantify liver fat, so it describes a measured association in a defined patient group rather than a causal pathway.[2]

Very high NT-proBNP is used in a different clinical context: guidance calls for urgent specialist assessment and echocardiography within two weeks when suspected heart failure accompanies a level above 2,000 nanograms per litre. This threshold addresses suspected heart failure, not fatty liver.[3]

What remains unresolved about liver fat and NT-proBNP

  • Does the association between lower NT-proBNP and liver fat persist when obesity, background, and treatments that can lower natriuretic peptides are accounted for?[2] [3]
  • How does NT-proBNP relate to the progression from simple liver fat to steatohepatitis and fibrosis, given that advanced fibrosis is linked with adverse outcomes and mortality?[4] [5]

Terms used in the evidence

NAFLD
Nonalcoholic fatty liver disease.[5]

Sources

  1. Fatty Liver Is Associated with Low N-Terminal Pro-B-Type Natriuretic Peptide in a Healthy Population (pmc.ncbi.nlm.nih.gov)
  2. Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes. (pubmed.ncbi.nlm.nih.gov)
  3. Recommendations | Chronic heart failure in adults: diagnosis and management | Guidance | NICE (www.nice.org.uk)
  4. Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD. (pubmed.ncbi.nlm.nih.gov)
  5. Global prevalence of advanced fibrosis in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the connection between BNP levels and Non-alcoholic fatty liver disease (NAFLD) in the context of type 2 diabetes?

Research indicates a significant correlation between lower levels of BNP and the presence of NAFLD in individuals with type 2 diabetes. The study showed that those with NAFLD had notably lower levels of NT-proBNP, a precursor to BNP. This link suggests that BNP might play a role in how the body processes fats, and that a deficiency could increase the risk of developing NAFLD. Specifically, the study found that lower NT-proBNP levels were independently associated with increased liver fat content.

2

How was the liver fat content measured in the study, and why is it important?

The study utilized 1H-magnetic resonance spectroscopy to precisely measure liver fat content in the participants. This sophisticated imaging technique allowed researchers to accurately determine the amount of fat accumulated in the liver. Accurate measurement of liver fat is crucial for diagnosing and understanding NAFLD, which is characterized by excessive fat buildup. The study defined NAFLD as a liver fat content exceeding 5.6%, which was a key factor in establishing the link between NT-proBNP levels and the presence of the disease.

3

Besides BNP, what other factors are involved in the relationship between liver health and type 2 diabetes?

The relationship between BNP and liver health is complex and involves several factors. The research suggests that insulin resistance and fat metabolism are significant players. The study specifically mentions adiponectin, a hormone regulating glucose levels and fatty acid breakdown, as potentially influencing the connection between BNP and liver fat. This implies that the interplay between BNP and NAFLD might involve complex interactions within fat tissue, including metabolic processes.

4

What does this research imply for individuals with type 2 diabetes in terms of their health management?

This research highlights the importance of a holistic approach to managing type 2 diabetes, considering the interconnectedness of the heart and the liver. Monitoring BNP levels could potentially become a useful tool in assessing the risk of NAFLD. Individuals with type 2 diabetes should discuss their BNP levels with their healthcare provider. It underscores the importance of considering the broader implications of metabolic health and the benefits of a comprehensive health assessment.

5

Can you elaborate on the role of Natriuretic peptides (NPs) like BNP in the body and how they connect to liver health?

Natriuretic peptides (NPs), particularly BNP, are traditionally known for their heart-related functions. However, recent research suggests that they also play a role in regulating metabolism, specifically how the body processes fats. Low levels of NPs have been observed in individuals with obesity and type 2 diabetes, potentially affecting fat distribution and increasing the risk of NAFLD. In the context of liver health, this implies that BNP could influence the accumulation of fat in the liver, with lower levels potentially contributing to the development or progression of NAFLD. This study specifically links the precursor NT-proBNP levels to liver fat content.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.